Professor Sir Mark Caulfield

Sir Caulfield graduated in Medicine in 1984 from the London Hospital Medical College and trained in Clinical Pharmacology at St Bartholomew’s Hospital where he developed a research programme in molecular genetics of hypertension and translational clinical research.
At Queen Mary University of London Caulfield has made substantial contributions to the discovery of > 2000 gene regions related to blood pressure, cardiovascular health, cancer and rare diseases. His research has changed national and international guidance for high blood pressure. Caulfield was Director of Queen Mary’s William Harvey Research Institute between 2002-2020 and was elected to the Academy of Medical Sciences in 2008.
Sir Caulfield was appointed Chief Scientist for Genomics England in 2013 and delivered the 100,000 Genomes Project using whole genome sequencing in rare disease, cancer and infection from which he co-created the National Genomic Test Directory and a new Genomic Medicine Service. He was awarded a knighthood in 2019 for his leadership of the 100,000 Genomes Project.
In July 2021, Sir Mark stepped down from his role as Chief Scientist for Genomics England to lead Barts Life Sciences. This is driving the development of a world-leading life sciences campus at Whitechapel focusing on digital precision healthcare. He is a member of the Barts Health NHS Trust Board.